Genetic architecture of gastric adenocarcinoma in West Asia

Saeid Latifi-Navid; Esmat Abdi; Tianpei Wang; Farhad Pourfarzi; Abbas Yazdanbod; Seyed Alireza Salami; Reza Safaralizadeh; Omolbanin Amjadi; Hamid Latifi-Navid; Bahareh Safarnejad; Mahmoud Shokrabadi; Iradj Maleki; Vahid Hosseini; Seyed Mohammad Valizadeh; Mehdi Pourghasemian; Negin Abediasl; Arash Kazemi; Mohammad Eslami Jouybari; Zohreh Bari; Tarang Taghvaei; Caiwang Yan; Amir Taher Eftekhar Sadat; Seyed Yaghoub Moaddab; Ghasem Janbabaei; Mohammad Hossein Somi; Alireza Sadjadi; Ramin Shakeri; Farideh Siavoshi; Hafez Fakheri; Hossein Poustchi; Reza Malekzadeh; Guangfu Jin

doi:10.1002/ctm2.70489

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (10) : e70489 DOI: 10.1002/ctm2.70489

LETTER TO THE JOURNAL

Genetic architecture of gastric adenocarcinoma in West Asia

Author information +

¹. Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran

². Health Management Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

³. Department of Health Management, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

⁴. Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

⁵. Department of Biotechnology, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran

⁶. Industrial and Medical Cannabis Research Institute (IMCRI), Tehran, Iran

⁷. Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran

⁸. Gastrointestinal Cancer Research Center, Non-communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran

⁹. Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran

¹⁰. Ardabil University of Medical Sciences, Ardabil, Iran

¹¹. Farabi Medical Laboratory, Ardabil, Iran

¹². Gut and Liver Research Center, Non-communicable Diseases Research Institutes, Mazandaran University of Medical Sciences, Sari, Iran

¹³. Department of Oncology, Ardabil University of Medical Sciences, Ardabil, Iran

¹⁴. Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China

¹⁵. Public Health Institute of Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China

¹⁶. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China

¹⁷. Department of Pathology, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran

¹⁸. Gastrointestinal and Liver Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

¹⁹. Department of Internal Medicine, School of Medicine, Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran

²⁰. Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran

²¹. School of Biology, University College of Sciences, University of Tehran, Tehran, Iran

s_latifi@uma.ac.ir

Show less

History +

PDF

Cite this article

Download citation ▾

Saeid Latifi-Navid, Esmat Abdi, Tianpei Wang, Farhad Pourfarzi, Abbas Yazdanbod, Seyed Alireza Salami, Reza Safaralizadeh, Omolbanin Amjadi, Hamid Latifi-Navid, Bahareh Safarnejad, Mahmoud Shokrabadi, Iradj Maleki, Vahid Hosseini, Seyed Mohammad Valizadeh, Mehdi Pourghasemian, Negin Abediasl, Arash Kazemi, Mohammad Eslami Jouybari, Zohreh Bari, Tarang Taghvaei, Caiwang Yan, Amir Taher Eftekhar Sadat, Seyed Yaghoub Moaddab, Ghasem Janbabaei, Mohammad Hossein Somi, Alireza Sadjadi, Ramin Shakeri, Farideh Siavoshi, Hafez Fakheri, Hossein Poustchi, Reza Malekzadeh, Guangfu Jin. Genetic architecture of gastric adenocarcinoma in West Asia. Clinical and Translational Medicine, 2025, 15(10): e70489 DOI:10.1002/ctm2.70489

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2024; 74(3): 229-263.

[2]	Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020; 69(5): 823-829.

[3]	Tanikawa C, Kamatani Y, Toyoshima O, et al. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. Cancer Sci. 2018; 109(12): 4015-4024.

[4]	Yan C, Zhu M, Ding Y, et al. Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations. Gut. 2020; 69(4): 641-651.

[5]	Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Archives Iranian Med. 2009; 12(6): 576-583.

[6]	de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015; 11(4): e1004219.

[7]	Kim HM, Kang B, Park S, et al. Forkhead box protein D2 suppresses colorectal cancer by reprogramming enhancer interactions. Nucleic Acids Res. 2023; 51(12): 6143-6155.

[8]	Jin G, Lv J, Yang M, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020; 21(10): 1378-1386.

[9]	Teng YS, Chen WY, Yan ZB, et al. L-plastin promotes gastric cancer growth and metastasis in a Helicobacter pylori cagA-ERK-SP1-dependent manner. Mol Can Res. 2021; 19(6): 968-978.

[10]	Chen XL, Hong LL, Wang KL, et al. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-kappaB pathway. Int J Biol Sci. 2019; 15(10): 2075-2086.

[11]	Kim YI, Pecha RL, Keihanian T, et al. MUC1 Expressions and its prognostic values in us gastric cancer patients. Cancers. 2023; 15(4).

[12]	Rajabi H, Kufe D. MUC1-C oncoprotein integrates a program of EMT, epigenetic reprogramming and immune evasion in human carcinomas. Biochimica et biophysica acta Rev Cancer. 2017; 1868(1): 117-122.

[13]	Echizen K, Hirose O, Maeda Y, Oshima M. Inflammation in gastric cancer: interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016; 107(4): 391-397.

[14]	Luo Q, Liu M, Tan Y, et al. Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis. Frontiers in Pharmacol. 2022; 13: 1004619.

[15]	Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nature Commun. 2017; 8(1): 1826.

[16]	Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genetics. 2014; 10(5): e1004383.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.